HIV Drug Resistance to Dolutegravir Among Adults Investigated for Anti-retroviral Treatment Failure in Malawi: A 2023 National Cross-sectional Survey

By afschroeder • August 22, 2025

Kalata NL, Bello G, Pals S, Kabaghe AN, Mkungudza J, Bighignoli B, Panja L, Bilaal W, Kusakale G, Chitenje M, Luhanga M, Zeh C, Kampira E, Chipeta S, Mvula B, Nyirenda R, Jahn A, Kagoli M, Maida A, O'Malley G, van Oosterhout JJ, Agyemang E, Zheng DP, Hackett S, Raizes E, Wadonda N, da Silva J. HIV Drug Resistance to Dolutegravir Among Adults Investigated for Anti-retroviral Treatment Failure in Malawi: A 2023 National Cross-sectional Survey. J Acquir Immune Defic Syndr. 2025 Aug 21. doi: 10.1097/QAI.0000000000003744. Epub ahead of print. PMID: 40839365.

Tags: dolutegravir, HIV Drug resistance, Infectious Diseases, Malawi, prevalence, Publications

Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV

Erlandson KM, Orkaby AR, Umbleja T, Ribaudo HJ, Brown TT, Zanni MV, Diggs MR, Chu SM, Fitch KV, Fichtenbaum CJ, Malvestutto C, Aberg JA, Bloomfield[...]

Late BK Nephropathy 15 years post kidney transplant following chemotherapy: A case report

Hamiduzzaman A, Hou J, Higgins T, Gaynor P, Shankar A, Lum EL. Late BK Nephropathy 15 years post kidney transplant following chemotherapy: A case report.[...]

Steroids, Seizures, and a Surprising Pathogen: A Case of Listeria Meningoencephalitis

Thangaratnam SM, Wilgus ML, Turner G, Brown CE, Landefeld K. Steroids, Seizures, and a Surprising Pathogen: A Case of Listeria Meningoencephalitis. Cureus. 2025 Jul 20;17(7):e88371.[...]